Investigator Sponsored Trials and Collaborative Studies
Investigator Sponsored Trials and Collaborative Studies support external researchers and Genmab’s study partners in clinical and preclinical research aimed at addressing unmet medical needs.
Funder: Genmab
Due Dates: No deadline stated
Funding Amounts: IST support may include funding and product; no award amount stated
Summary: Genmab supports external investigator-led research and collaborative studies aimed at addressing unmet medical needs.
Key Information: ISTs must be initiated and managed by a non-pharmaceutical company researcher.
Description
Genmab’s Investigator Sponsored Trials (ISTs) and Collaborative Studies programs support research intended to uncover opportunities to address unmet medical needs. ISTs are initiated and managed by an external researcher acting as Sponsor Investigator. They may be clinical or preclinical, including interventional and observational studies, in-vitro projects, and analyses of banked clinical samples.
Collaborative Studies are prospective human studies conducted by Genmab and a Collaborative Study Partner to generate primary data. They may be interventional or non-interventional and can originate with either partner. Genmab’s portal identifies areas of interest involving epcoritamab-bysp, tisotumab vedotin, rinatabart sesutecan (Rina-S), and petosemtamab.
